Merck and Ridgeback Biotherapeutics' promising oral antiviral could shift the direction of the pandemic by making it easier for people with COVID-19 to take a pill at home that can keep them from getting severely sick.

from MarketWatch.com - Top Stories https://ift.tt/3or0JNI
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3or0JNI
via IFTTT
Kommentare
Kommentar veröffentlichen